@misc{indiciae2d7a5a3fd542,
  title = {Uttroside B, a US FDA-designated Orphan drug, mitigates thedevelopment of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3},
  author = {Keerthana, C. K. and Rayginia, T. P. and Kalimuthu, K. and Saha, S. and Haritha, N. H. and A, A. N. and Swetha, M. and Aiswarya, S. U. and Nath, L. R. and Varma, S. S. and Viswanathan, A. and S, J. and J, S. and JS, A. and Praveen, A. and Jaikumar, V. S. and Sundaram, S. and Anto, N. P. and Maiti, T. K. and C, S. and Isakov, N. and Lankalapalli, R. S. and Harikumar, K. B. and Anto, R. J.},
  year = {2025},
  doi = {10.1101/2025.07.22.666080},
  url = {https://www.biorxiv.org/content/10.1101/2025.07.22.666080v1},
  note = {Source identifier: 10.1101/2025.07.22.666080}
}